FDA Approves Wynzora® Cream for Plaque Psoriasis

| Samantha Koons

Plaque psoriasis is the most common type of psoriasis, with approximately 80 percent to 90 percent of patients with psoriasis developing plaques.[1] On July 22, 2020, the U.S. Food and Drug Administration approved Wynzora® cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%) for the treatment of plaque psoriasis in adult patients.

Wynzora® cream marks the first cream formulation of a vitamin D based treatment (calcipotriene) and a corticosteroid (betamethasone dipropionate). Using proprietary PAD™ Technology, researchers developed a way to enable stability of both treatments in a cream formulation that is meant to be convenient for patients to use.

Data from phase 3 trials of Wynzora® cream showed it to have statistically significant treatment efficacy as well as favorable patient-reported outcomes, compared to another calcipotriene and betamethasone dipropionate topical treatment.

Manufacturer, MC2 Therapeutics, is also investigating drug candidates for other indications such as atopic dermatitis.


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Even during a pandemic, your voice matters.
When COVID-19 struck and society shut down, digital advocacy grew up – fast.
How to stand up for yourself in the face of surprise medical bills.
several npf staff and volunteers advocating on capitol hill day
A longtime NPF member and psoriatic disease patient shares his experience in...
There’s power in numbers. Join us April 21 when we stand up for everyone with...
How the voice of the patient makes a difference in your state and nationally.
Let’s get to the bottom of what it really means to be an advocate.
NPF meets with other national health care organizations about access to care...
Dial in to our summer series of advocacy calls and connect with others living...